Aledade CEO Farzad Mostashari Named Among Modern Healthcare’s 50 Most Influential Clinical Executives of 2026
Event summary
- Farzad Mostashari, CEO of Aledade, recognized as one of Modern Healthcare’s 50 Most Influential Clinical Executives of 2026.
- Aledade partners with over 3,000 primary care organizations across 46 states, serving more than 3 million patients.
- In 2024, Aledade ACOs prevented 263,000 unnecessary hospitalizations and achieved $1 billion in Medicare savings.
- Mostashari emphasizes fixing incentive structures to drive better healthcare outcomes.
The big picture
Aledade’s recognition underscores the growing influence of value-based care models in healthcare. With 511 ACOs participating in the Medicare Shared Savings Program in 2026, the shift from fee-for-service to outcome-based reimbursement is accelerating. Mostashari’s leadership highlights the strategic importance of aligning incentives to improve patient outcomes and financial sustainability for primary care providers.
What we're watching
- Value-Based Care Adoption
- Whether Aledade can sustain its growth in value-based care contracts amid increasing competition.
- Policy Influence
- The impact of Aledade’s Policy Institute on shaping federal healthcare regulations.
- Primary Care Focus
- How Aledade’s emphasis on primary care will affect its long-term market positioning.
Related topics